Daily non-political popular news in brief.
Mayo discovers protein as potential tactic to prevent tumors
10-12-2006 · EurekAlert!Mayo Clinic researchers have found that a protein that initiates a "quality control check" during cell division also directs cell death for those cells damaged during duplication. This knowledge represents a potential "bulls eye" for targeting anti-tumor drugs. The findings appear in the current issue of Science.
Read more »
Keywords: mayo, discovers, protein, potential, tactic, prevent, tumors, discover, tumor
« Previous | Next »
Similar news on "Mayo discovers protein as potential tactic to prevent tumors":
- Jefferson scientists find blood vessel-building protein halts blood vessels from forming in cancer
11-14-2006 · EurekAlert!
A piece of the protein cellular scaffolding involved in building blood vessels duringdevelopment might have the opposite effect in tumors. Scientists have found that the protein fragment endorepellin blocks both skin and lung cancer tumors from progressing in animal models by preventing their ability to recruit new blood vessels, a process called angiogenesis. The researchers believe the finding could lead to a new type of tumor inhibitor to prevent cancer from spreading.
Similar news · Read more »
- Newly identified biomarker detects and regulates spread of brain tumors
11-10-2006 · EurekAlert!
Researchers have identified a novel biomarker for brain tumors and have uncovered a potential role the marker may play when the tumor spreads or comes back after treatment. The biomarker, a protein known as "soluble attractin," is normally absent in the central nervous system and is undetectable in cerebral spinal fluid unless malignant astrocytomas are present in the CNS. This newfound ability to identify biomarkers for malignant astrocytomas means physicians will have a minimally invasive method to track the success of treatments.
Similar news · Read more »
- Blocking beta1-integrin to treat cancer
06-06-2007 · EurekAlert!
Targeting the function of a protein known as beta1-integrin might represent a novelapproach to cancer treatment, according to a paper published online in The EMBO Journalthis week. Blocking the action of this protein could help to prevent the formation ofmetastases by reducing tumor cell proliferation and inducing cell senescence.
Similar news · Read more »
- AVN944 inhibits IMPDH & induces apoptosis-related biomarkers in patients with hematologic cancers
12-11-2006 · EurekAlert!
IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
Similar news · Read more »
- Drug blocks lethal motor-neuron disease in mice
02-22-2007 · EurekAlert!
Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations in the gene SMN1 that prevent it producing the protein SMN. New research shows that in a lethal mouse model of SMA the drug trichostatin A (TSA), which is a hydroxamic acid HDAC inhibitor, can improve survival and attenuate disease, indicating that hydroxamic acid HDAC inhibitors might be potential therapeutics for the treatment of individuals with SMA.
Similar news · Read more »
- AVN944 inhibits IMPDH and induces apoptosis-related biomarkers in patients with hematologic cancers
12-11-2006 · EurekAlert!
IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
Similar news · Read more »
- Researchers find two biomarkers with potential to predict breast cancer spread
12-15-2006 · EurekAlert!
Expression of two different proteins taken from primary tumor biopsies is highly associated with spread of breast cancer to nearby lymph nodes, according to researchers who say this protein profile could help identify at an early stage those patients whose disease is likely to metastasize.
Similar news · Read more »
- New angiogenesis inhibitor has promise for treating deadly brain tumor
01-16-2007 · EurekAlert!
Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs.
Similar news · Read more »
- Scientists take next step in understanding potential target for Ovarian cancer treatment
07-16-2007 · EurekAlert!
A traffic cop protein in the cell may have an even more important role: transporting a messenger protein that tells components in the nucleus to stop cell growth. Scientists are studying the normal function of a protein called 'km23', the traffic cop protein, because the team previously found altered forms of the protein in 42 percent of tumor tissue samples taken from women with Ovarian cancer. The discovery of this additional role may lead to diagnostic tools and earlier treatments for Ovarian cancer.
Similar news · Read more »
- Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread
01-10-2008 · EurekAlert!
A protein that helps prevent a woman's body from rejecting a fetus may also play an important role in enabling pancreatic cancer cells to evade detection by the immune system, allowing them to spread in the body. Researchers found that the metastatic pancreatic cancer cells in the lymph nodes produce enough of the protein, IDO, to wall-off the immune system's T-cells and recruit cells that suppress the immune response to the tumor.
Similar news · Read more »
